AXL and cancer: As summarised in Fig. 8, we propose a mechanistic model in which dual targeting of CAV1 and AXL impairs the pro-survival signalling via STAT3, AMPKα, and RAC pathways, thereby promoting excessive autophagy and inducing cancer cell death to overcome TKI resistance in HCC.